Literature DB >> 31890689

Patient and physician preferences for type 2 diabetes medications: a systematic review.

Mahdi Toroski1, Abbas Kebriaeezadeh1,2, Alireza Esteghamati3, Ali Kazemi Karyani4, Hadi Abbasian1, Shekoufeh Nikfar1.   

Abstract

BACKGROUND: There are several treatments to cure type 2 diabetes (T2D) and every one of them has certain attributes which is lead patients and specialists to have different preferences and select power. Therefore, we did this systematic study to evaluate patients̓ and physicians̓ preferences for type 2 diabetes medications by extracting attributes of anti-diabetic medications and identifying their relative importance.
METHODS: We searched the PubMed, Ovid, Web of science, Scopus and Embase databases for articles which have been published on or before May 8th, 2018(The start time of the search in our study was May 8th, 2018).
RESULTS: The searches identified 3346 studies, of which 17 (from 2009 to 2017) were included in the final synthesis and 27 attributes of type 2 anti-diabetic have been investigated. The most important attributes are changes of blood glucose and HbA1c level, hypoglycemia events, weight changes, gastrointestinal complications, cardiovascular effects, medicines cost, and administration mode and dosage of medicines.
CONCLUSION: physicians and patients prefer antidiabetics which is reduce blood glucose and HbA1c level effectively and have low side effects too (hypoglycemic event, cardiovascular and gastrointestinal). The effect of weight reduction, low cost, low dosing and low frequency of using. Health care providers, Specialist, and manufacturers should consider to these attributes in treatment process and marketing. It can increase adherence to management approaches, and reduce morbidity of patients with type 2 diabetes. © Springer Nature Switzerland AG 2019.

Entities:  

Keywords:  Diabetes type 2; Patient preferences; Physician; Systematic review

Year:  2019        PMID: 31890689      PMCID: PMC6915252          DOI: 10.1007/s40200-019-00449-4

Source DB:  PubMed          Journal:  J Diabetes Metab Disord        ISSN: 2251-6581


  47 in total

Review 1.  Diabetes, cardiovascular disease, and chronic kidney disease in South Asia: current status and future directions.

Authors:  Anoop Misra; Nikhil Tandon; Shah Ebrahim; Naveed Sattar; Dewan Alam; Usha Shrivastava; K M Venkat Narayan; Tazeen H Jafar
Journal:  BMJ       Date:  2017-04-11

2.  Willingness to pay for improvements in chronic long-acting insulin therapy in individuals with type 1 or type 2 diabetes mellitus.

Authors:  Andrew Lloyd; Beenish Nafees; Anthony H Barnett; Simon Heller; Uffe J Ploug; Morten Lammert; Mette Bøgelund
Journal:  Clin Ther       Date:  2011-08-20       Impact factor: 3.393

3.  The global economic burden of diabetes in adults aged 20-79 years: a cost-of-illness study.

Authors:  Christian Bommer; Esther Heesemann; Vera Sagalova; Jennifer Manne-Goehler; Rifat Atun; Till Bärnighausen; Sebastian Vollmer
Journal:  Lancet Diabetes Endocrinol       Date:  2017-04-26       Impact factor: 32.069

Review 4.  Patient preferences versus physicians' judgement: does it make a difference in healthcare decision making?

Authors:  Axel C Mühlbacher; Christin Juhnke
Journal:  Appl Health Econ Health Policy       Date:  2013-06       Impact factor: 2.561

5.  Treatment preferences and medication adherence of people with Type 2 diabetes using oral glucose-lowering agents.

Authors:  A B Hauber; A F Mohamed; F R Johnson; H Falvey
Journal:  Diabet Med       Date:  2009-04       Impact factor: 4.359

6.  A valuation of patients' willingness-to-pay for insulin delivery in diabetes.

Authors:  Camila Guimarães; Carlo A Marra; Lindsey Colley; Sabrina Gill; Scot H Simpson; Graydon S Meneilly; Regina H C Queiroz; Larry D Lynd
Journal:  Int J Technol Assess Health Care       Date:  2009-07       Impact factor: 2.188

7.  Gastrointestinal complications of diabetes mellitus.

Authors:  Babu Krishnan; Shithu Babu; Jessica Walker; Adrian B Walker; Joseph M Pappachan
Journal:  World J Diabetes       Date:  2013-06-15

8.  Preferences for medication attributes among patients with type 2 diabetes mellitus in the UK.

Authors:  H L Gelhorn; S M Stringer; A Brooks; C Thompson; B U Monz; K S Boye; T Hach; S S Lund; R Palencia
Journal:  Diabetes Obes Metab       Date:  2013-04-07       Impact factor: 6.577

9.  Physician preferences for extra-glycemic effects of type 2 diabetes treatments.

Authors:  Christine Poulos; Juan Marcos González; Lauren J Lee; Kristin S Boye; F Reed Johnson; Jay P Bae; Mark A Deeg
Journal:  Diabetes Ther       Date:  2013-11-20       Impact factor: 2.945

10.  Barriers and facilitators to adherence to anti-diabetic medications: Ethiopian patients' perspectives.

Authors:  Bruck M Habte; Tedla Kebede; Teferi G Fenta; Heather Boon
Journal:  Afr J Prim Health Care Fam Med       Date:  2017-10-17
View more
  5 in total

Review 1.  Methods to Summarize Discrete-Choice Experiments in a Systematic Review: A Scoping Review.

Authors:  Daksh Choudhary; Megan Thomas; Kevin Pacheco-Barrios; Yuan Zhang; Pablo Alonso-Coello; Holger Schünemann; Glen Hazlewood
Journal:  Patient       Date:  2022-07-13       Impact factor: 3.481

2.  Patient preferences for the treatment of type 2 diabetes in Australia: a discrete choice experiment.

Authors:  Akram Ahmad; Muhammad Umair Khan; Parisa Aslani
Journal:  J Diabetes Metab Disord       Date:  2022-01-27

3.  AntiDMPpred: a web service for identifying anti-diabetic peptides.

Authors:  Xue Chen; Jian Huang; Bifang He
Journal:  PeerJ       Date:  2022-06-14       Impact factor: 3.061

4.  Empagliflozin treatment effects across categories of baseline HbA1c, body weight and blood pressure as an add-on to metformin in patients with type 2 diabetes.

Authors:  Silvio E Inzucchi; Melanie J Davies; Kamlesh Khunti; Prabhav Trivedi; Jyothis T George; Isabella Zwiener; Odd Erik Johansen; Naveed Sattar
Journal:  Diabetes Obes Metab       Date:  2020-11-20       Impact factor: 6.577

Review 5.  The Perspectives of Patients with Chronic Diseases and Their Caregivers on Self-Management Interventions: A Scoping Review of Reviews.

Authors:  Ena Niño de Guzmán Quispe; Laura Martínez García; Carola Orrego Villagrán; Monique Heijmans; Rosa Sunol; David Fraile-Navarro; Javier Pérez-Bracchiglione; Lyudmil Ninov; Karla Salas-Gama; Andrés Viteri García; Pablo Alonso-Coello
Journal:  Patient       Date:  2021-04-19       Impact factor: 3.883

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.